CIP2A expression and prognostic role in patients with esophageal adenocarcinoma

Rantanen, Tuomo; Kauttu, Tuuli; Åkerla, Jonne; Honkanen, Teemu; Krogerus, Leena; Salo, Jarmo; Paavonen, Timo; Oksala, Niku
September 2013
Medical Oncology;Sep2013, Vol. 30 Issue 3, p1
Academic Journal
No abstract available.


Related Articles

  • P66shc and its downstream Eps8 and Rac1 proteins are upregulated in esophageal cancers. Bashir, Muneesa; Kirmani, Deeba; Bhat, Hina F.; Baba, Rafia A.; Hamza, Rouf; Naqash, Sameer; Wani, Nisar A.; Andrabi, Khurshid I.; Zargar, Mohammad A.; Khanday, Firdous A. // Cell Communication & Signaling;2010, Vol. 8, p13 

    Members of Shc (src homology and collagen homology) family, p46shc, p52shc, p66shc have known to be related to cell proliferation and carcinogenesis. Whereas p46shc and p52shc drive the reaction forward, the role of p66shc in cancers remains to be understood clearly. Hence, their expression in...

  • IS THERE A SURGICAL NIRVANA FOR BARETT'S ESOPHAGUS? Öberg, Stefan; Mason, Rodney J.; Johnson, David // American Journal of Gastroenterology;Dec1996, Vol. 91 Issue 12, p2630 

    Discusses the antireflux surgery of patients with Barrett's esophagus. Definition of Barrett's esophagus; Information on the occurrence of esophageal adenocarcinoma; Role of antireflux procedure in the development of adenocarcinoma;

  • Esophageal carcinoma cell line with high EGFR polysomy is responsive to gefitinib. Drenckhan, Astrid; Grob, Tobias; Dupree, Anna; Dohrmann, Thorsten; Mann, Oliver; Izbicki, Jakob; Gros, Stephanie // Langenbeck's Archives of Surgery;Oct2014, Vol. 399 Issue 7, p879 

    Purpose: It has previously been shown that gefitinib-treated patients with epidermal growth factor receptor (EGFR) gene amplification or high polysomy had a statistically significant improvement in response, time to progression, and survival in non-small cell lung cancer (NSCLC). Only few...

  • Proinflammatory Cytokine and Nuclear Factor Kappa-B Expression along the Inflammation—Metaplasia—Dysplasia—Adenocarcinoma Sequence in the Esophagus. O'Riordan, J. M.; Abdel-latif, M. M.; Ravi, N.; McNamara, D.; Byrne, P. J.; McDonald, G. S. A.; Keeling, P. W. N.; Kelleher, D.; Reynolds, J. V. // American Journal of Gastroenterology;Jun2005, Vol. 100 Issue 6, p1257 

    BACKGROUND: The incidence of esophageal adenocarcinoma has increased significantly in the western world over the last 20 yr. Most cases arise in a background of chronic gastroesophageal reflux, and specialized intestinal metaplasia in Barrett's esophagus is frequently an antecedent phenotype or...

  • Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. Choy, Bonnie; Bandla, Santhoshi; Yinglin Xia; Dongfeng Tan; Pennathur, Arjun; Luketich, James D.; Godfrey, Tony E.; Peters, Jeffrey H.; Jun Sun; Zhongren Zhou // BMC Gastroenterology;2012, Vol. 12 Issue 1, p146 

    Background: High expression of Bmi-1, a key regulatory component of the polycomb repressive complex-1, has been associated with many solid and hematologic malignancies including esophageal squamous cell carcinoma. However, little is known about the role of Bmi-1 in esophageal adenocarcinoma. The...

  • IGF-1 and Its Receptor in Esophageal Cancer: Association with Adenocarcinoma and Visceral Obesity. Doyle, Suzanne L; Donohoe, Claire L; Finn, Stephen P; Howard, Julia M; Lithander, Fiona E; Reynolds, John V; Pidgeon, Graham P; Lysaght, Joanne // American Journal of Gastroenterology;Feb2012, Vol. 107 Issue 2, p196 

    OBJECTIVES:The insulin-like growth factor (IGF) pathway and visceral obesity have been independently linked with esophageal cancer. This study aimed to delineate the differential and interlinked role of visceral obesity and the IGF-1 system in esophageal adenocarcinoma and esophageal...

  • Epidermal Growth Factor Receptor Expression in Esophageal Adenocarcinoma: Relationship with Tumor Stage and Survival after Esophagectomy. Navarini, Daniel; Gurski, Richard R.; Madalosso, Carlos Augusto; Aita, Lucas; Meurer, Luise; Fornari, Fernando // Gastroenterology Research & Practice;2012, p1 

    Background and Aims. Esophageal adenocarcinoma (EA) is an aggressive tumor with increasing incidence in occidental countries. Several prognostic biomarkers have been proposed, including epidermal growth factor receptor (EGFR). The aim of this study was to assess whether EGFR expression predicts...

  • CXCR7 expression in esophageal cancer. Tachezy, Michael; Zander, Hilke; Gebauer, Florian; von Loga, Katharina; Pantel, Klaus; Izbicki, Jakob R.; Bockhorn, Maximilian // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background: The chemokine CXCL12 and its receptor CXCR4 play a major role in tumor invasion, proliferation and metastasis in different malignant diseases, including esophageal carcinoma, amongst others. CXCR7 was recently identified as a novel alternate receptor for CXCL12. The aim of this study...

  • Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma. Qing Wang; Chenming Ma; Kemmner, Wolfgang // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: We attempted to identify novel biomarkers and therapeutic targets for esophageal squamous cell carcinoma by gene expression profiling of frozen esophageal squamous carcinoma specimens and examined the functional relevance of a newly discovered marker gene, WDR66. Methods: Laser...

  • Prognostic relevance of Centromere protein H expression in esophageal carcinoma. Xian-Zhi Guo; Ge Zhang; Jun-Ye Wang; Wan-Li Liu; Fang Wang; Ju-Qin Dong; Li-Hua Xu; Jing-Yan Cao; Li-Bing Song; Mu-Sheng Zeng // BMC Cancer;2008, Vol. 8, Special section p1 

    Background: Many kinetochore proteins have been shown to be associated with human cancers. The aim of the present study was to clarify the expression of Centromere protein H (CENP-H), one of the fundamental components of the human active kinetochore, in esophageal carcinoma and its correlation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics